Drug safety risk assessment system

Abstract

The invention discloses a drug safety risk assessment system, and belongs to the technical field of drug safety risk assessment, and the system comprises a drug classification module which is used for classifying to-be-assessed drugs; the character analysis module is used for analyzing to-be-evaluated drug characters; the detection method evaluation module is used for providing the most suitable evaluation method for the medicine to be evaluated; the risk assessment module is used for performing risk assessment on the to-be-assessed medicine; according to the invention, to-be-assessed drugs are classified through the drug classification module, the traits of the to-be-assessed drugs are analyzed through the traits analysis module, the detection method assessment module provides a most suitable assessment method for the to-be-assessed drugs, and the risk assessment module carries out risk assessment on the to-be-assessed drugs. Therefore, the corresponding risk assessment scheme can be quickly matched to comprehensively assess the safety risk of the medicine, the safety problem of the medicine can be found and prevented in advance, and the safety and effectiveness of medicine use of a patient can be guaranteed.

Description

Technical Field

[0001] The present invention belongs to the technical field of drug safety risk assessment, and in particular relates to a drug safety risk assessment system. Background Art

[0002] Drug safety risk assessment refers to the process of analyzing and evaluating adverse events and safety issues that may occur during the use of drugs.

[0003] At present, the drug safety risk assessment system is not comprehensive enough, which leads to the failure to detect drug safety issues in a timely manner. Summary of the invention

[0004] The purpose of the present invention is to propose a drug safety risk assessment system in order to solve the above-mentioned problems.

[0005] In order to achieve the above object, the present invention adopts the following technical solution: a drug safety risk assessment system, comprising:

[0006] A drug classification module, which is used to classify the drugs to be evaluated;

[0007] A property analysis module, which is used to analyze the properties of the drug to be evaluated;

[0008] A detection method evaluation module, which is used to provide the most suitable evaluation method for the drug to be evaluated;

[0009] The risk assessment module is used to perform risk assessment on the drug to be assessed.

[0010] As a further description of the above technical solution:

[0011] The drug classification module is connected to the drug classification database unit.

[0012] As a further description of the above technical solution:

[0013] The detection method evaluation module is connected to the detection method database unit.

[0014] As a further description of the above technical solution:

[0015] The risk assessment module includes a drug chemical property assessment unit, a clinical trial data assessment unit, a drug production process assessment unit, a drug use risk assessment unit and a drug monitoring and feedback assessment unit.

[0016] In summary, due to the adoption of the above technical solution, the beneficial effects of the present invention are:

[0017] In the present invention, the drugs to be evaluated are classified by the drug classification module, the properties analysis module analyzes the properties of the drugs to be evaluated, the detection method evaluation module provides the most suitable evaluation method for the drugs to be evaluated, and the risk assessment module performs risk assessment on the drugs to be evaluated. The corresponding risk assessment scheme can be quickly matched to conduct a comprehensive assessment of the safety risks of the drugs, discover and prevent safety problems of the drugs in advance, and ensure the safety and effectiveness of patients' medication. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1 A block diagram of a drug safety risk assessment system.

[0019] Legend:

[0020] 1. Drug classification module; 2. Property analysis module; 3. Detection method evaluation module; 4. Risk assessment module; 41. Drug chemical properties evaluation unit; 42. Clinical trial data evaluation unit; 43. Drug production process evaluation unit; 44. Drug use risk assessment unit; 45. Drug monitoring and feedback evaluation unit; 5. Drug classification database unit; 6. Detection method database unit. DETAILED DESCRIPTION

[0021] In order to make the purpose, technical solution and advantages of the embodiment of the present invention clearer, the technical solution in the embodiment of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiment of the present invention. Obviously, the described embodiment is a part of the embodiment of the present invention, rather than all the embodiments. The components of the embodiment of the present invention described and shown in the drawings here can be arranged and designed in various different configurations. Therefore, the following detailed description of the embodiment of the present invention provided in the drawings is not intended to limit the scope of the claimed invention, but only represents the selected embodiment of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention. It should be noted that similar numbers and letters represent similar items in the following drawings, so once an item is defined in one drawing, it does not need to be further defined and explained in the subsequent drawings. In the description of the embodiments of the present invention, it should be noted that the terms "upper", "inside", etc. indicate the orientation or positional relationship based on the orientation or positional relationship shown in the accompanying drawings, or the orientation or positional relationship in which the invented product is usually placed when in use, which is only for the convenience of describing the present invention and simplifying the description, rather than indicating or implying that the device or element referred to must have a specific orientation, be constructed and operated in a specific orientation, and therefore cannot be understood as a limitation of the present invention. In the description of the present invention, it should also be noted that, unless otherwise clearly specified and limited, the terms "set", "install", "connected", and "connected" should be understood in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral connection; it can be directly connected, or indirectly connected through an intermediate medium, or it can be the internal connection of two elements. For those of ordinary skill in the art, the specific meanings of the above terms in the present invention can be understood according to specific circumstances.

[0022] See also Figure 1 The present invention provides a technical solution: a drug safety risk assessment system, comprising:

[0023] A drug classification module 1, which is used to classify the drugs to be evaluated;

[0024] A property analysis module 2, which is used to analyze the properties of the drug to be evaluated;

[0025] A detection method evaluation module 3, which is used to provide the most suitable evaluation method for the drug to be evaluated;

[0026] A risk assessment module 4, which is used to perform risk assessment on the drug to be assessed;

[0027] The drug classification module 1 is connected to the drug classification database unit 5;

[0028] The detection method evaluation module 3 is connected to the detection method database unit 6;

[0029] The risk assessment module 4 includes a drug chemical property assessment unit 41, a clinical trial data assessment unit 42, a drug production process assessment unit 43, a drug use risk assessment unit 44 and a drug monitoring and feedback assessment unit 45;

[0030] Drug Chemical Properties Evaluation Unit 41, which evaluates the pharmacological, pharmacokinetic, and toxicological properties of drugs to determine the safety of drug use;

[0031] Clinical trial data evaluation unit 42, which evaluates the efficacy and safety data of drugs in clinical trials to determine the indications and dosage ranges of the drugs, and evaluates common adverse events and safety issues during drug use;

[0032] Pharmaceutical production process assessment unit 43, which assesses the production process and quality management system of pharmaceuticals to ensure that the pharmaceuticals are not affected by factors such as contamination and deterioration during the production process;

[0033] Drug use risk assessment unit 44, which assesses possible adverse events and safety issues that may occur during actual drug use, including adverse drug reactions, drug interactions, drug abuse and misuse;

[0034] Drug Monitoring and Feedback Evaluation Unit 45 evaluates the drug monitoring and feedback system, including the reporting and handling mechanism for adverse drug events, and the long-term monitoring and evaluation mechanism for drugs.

[0035] Working principle: First, the drugs to be evaluated are classified through the drug classification module 1. Secondly, the property analysis module 2 analyzes the properties of the drugs to be evaluated. Then, the detection method evaluation module 3 provides the most suitable evaluation method for the drugs to be evaluated. Finally, the risk assessment module 4 performs risk assessment on the drugs to be evaluated, and can quickly match the corresponding risk assessment plan to conduct a comprehensive assessment of the safety risks of the drugs, discover and prevent safety problems of drugs in advance, and ensure the safety and effectiveness of patients' medication.

[0036] The above description is only a preferred specific implementation manner of the present invention, but the protection scope of the present invention is not limited thereto. Any technician familiar with the technical field can make equivalent replacements or changes according to the technical scheme and inventive concept of the present invention within the technical scope disclosed by the present invention, which should be covered by the protection scope of the present invention.

Claims

1. A drug safety risk assessment system, characterized in that: include: A drug classification module (1), which is used to classify the drugs to be evaluated; A property analysis module (2), which is used to analyze the property of the drug to be evaluated; A detection method evaluation module (3), which is used to provide the most suitable evaluation method for the drug to be evaluated; The risk assessment module (4) is used to perform risk assessment on the drug to be assessed.

2. A drug safety risk assessment system according to claim 1, characterized in that: The medicine classification module (1) is connected to a medicine classification database unit (5).

3. A drug safety risk assessment system according to claim 1, characterized in that: The detection method evaluation module (3) is connected to the detection method database unit (6).

4. A drug safety risk assessment system according to claim 1, characterized in that: The risk assessment module (4) includes a drug chemical property assessment unit (41), a clinical trial data assessment unit (42), a drug production process assessment unit (43), a drug use risk assessment unit (44) and a drug monitoring and feedback assessment unit (45).

Images